| 10530-4 | Aprobarbital | DRUG/TOX |
| 105300-8 | Hemoglobin in Mixed venous blood | HEM/BC |
| 105302-4 | Immune stain PD-L1 scoring method - Tissue | PATH |
| 105303-2 | Tumor cells+Macrophages+Lymphocytes.Programmed cell death ligand 1/Viable tumor cells (Tissue, immune stain) | PATH |
| 105304-0 | Tumor cells.Programmed cell death ligand 1/Viable tumor cells (Tissue, immune stain) | PATH |
| 105305-7 | Tumor area infiltrated with PD-L1 expressing immune cells/Total tumor area (Tissue, immune stain) | PATH |
| 10531-2 | Bretylium | DRUG/TOX |
| 10532-0 | Desethylamiodarone | DRUG/TOX |
| 105327-1 | Glial fibrillary acidic protein (Blood, immunoassay) | SERO |
| 105328-9 | Ubiquitin carboxyl-terminal hydrolase-L1 (Blood, immunoassay) | SERO |
| 105329-7 | Hereditary angioedema multigene analysis (Blood, molecular genetics method) | MOLPATH |
| 10533-8 | Propoxyphene+Acetaminophen | DRUG/TOX |
| 105330-5 | Hereditary bleeding disorders multigene analysis in Specimen (molecular genetics method) | MOLPATH |
| 105331-3 | Hereditary bleeding disorders factor and von Willebrand multigene analysis in Specimen (molecular genetics method) | MOLPATH |
| 105332-1 | MYH9 gene full mutation analysis (Blood, molecular genetics method) | MOLPATH |
| 105333-9 | Hereditary platelet function defect multigene analysis (Blood, molecular genetics method) | MOLPATH |
| 105334-7 | Hereditary platelet disorders multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105335-4 | Hereditary platelet storage pool deficiency multigene analysis (Blood, molecular genetics method) | MOLPATH |
| 105336-2 | Hereditary thrombosis disorders multigene analysis (Blood, molecular genetics method) | MOLPATH |
| 105337-0 | VWF and GP1BA gene mutation analysis in Specimen (molecular genetics method) | MOLPATH |
| 105338-8 | Endomysium IgG Ab (qualitative, immunofluorescence) | SERO |
| 105339-6 | Chlamydia trachomatis L1 DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 10534-6 | Diazoxide | DRUG/TOX |
| 105340-4 | Chlamydia trachomatis L3 DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 105341-2 | 2-Hydroxyglutarate aciduria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105342-0 | 3-Methylglutaconate aciduria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105343-8 | Acute myeloid Leukemia multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105344-6 | Acute porphyria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105345-3 | Cholestasis multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105346-1 | Glycosylation congenital disorders multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105347-9 | Methylmalonate aciduria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105348-7 | Methylmalonate aciduria-propionic aciduria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105349-5 | Neuronal ceroid lipofuscinosis multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 10535-3 | Digoxin | DRUG/TOX |
| 105350-3 | Porphyria multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105351-1 | Hereditary erythrocytosis multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105352-9 | Congenital lactic acidosis multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105353-7 | Fatty acid oxidation multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105354-5 | Glutarate aciduria 2 multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105355-2 | Maple syrup urine disease multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 105356-0 | Number of days having an air quality index value (AQI) | PHENX |
| 105357-8 | Number of days having an AQI value 0 through 50 | PHENX |
| 105358-6 | Number of days having an AQI value 51 through 100 | PHENX |
| 105359-4 | Maximum air quality index (AQI) | PHENX |
| 10536-1 | Dipyridamole | DRUG/TOX |
| 105360-2 | 90 percent of daily air quality index (AQI) values | PHENX |
| 105361-0 | Number of days carbon monoxide | PHENX |
| 105362-8 | Number of days nitrogen dioxide | PHENX |
| 105363-6 | Number of days ozone | PHENX |
| 105364-4 | Number of days having an AQI value 101 through 150 | PHENX |